doi: 10.1038/npp.2017.160
medscape.com To view or add a comment, sign in I wanted to share key take-aways from the recent joint statement by hepatology and diabetes experts: Management of patients with type 2 diabetes and MASLD: an overview and joint statement (Chouik Y et al., 2025)
[4] In the SURMOUNT-1 obesity trial, a 72-week placebo-controlled study in 2,539 adults with obesity (without diabetes), mean weight change was 15.0%, 19.5%, and 20.9% at the 5, 10, and 15 mg doses versus 3.1% for placebo
Beyond The Scale Wellness is more than just losing weight
These are: Ozempic (semaglutide) Wegovy (semaglutide) Rybelsus (oral semaglutide) Bydureon (exenatide) Trulicity (dulaglutide) Victoza (liraglutide) Adlyxin (lixisenatide) Byetta (exenatide) These medications may be used and administered in specific ways, depending on your dosage and condition
The tissue under the tongue is highly vascular, with direct access to systemic circulation